PUBLISHED ON: August 18, 2011 | Duration: 2 min, 44 sec
Pharma giant Abbott is charting out big growth plans in the $20-billion Indian pharma market. The firm says India is a top priority in the emerging markets, a segment which contributes over a quarter to Abbott's global sales.
